Sofia Feigelman

Dr. Sofia Feigelman

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Cells
Verified
Journal Article
Open access
PDF file
ABAndrey Budnevsky
Andrey Budnevsky
SASergey Avdeev
Sergey Avdeev
Djuro KosanovicDjuro Kosanovic
Djuro Kosanovic
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
ISInessa A. Savushkina
Inessa A. Savushkina
IPInna Mikhailovna Perveeva
Inna Mikhailovna Perveeva
Recent studies suggested the potential role of mast cells (MCs) in the pathology of coronavirus disease 2019 (COVID-19). However, the precise description of the MCs’ activation and the engagement of their proteases is still missing. The objective of this study was to further reveal the importance of MCs and their proteases (chymase, tryptase, and carboxypeptidase A3 (CPA3)) in the development of lung damage in patients with COVID-19. This study included 55 patients who died from COVID-19 and 30 controls who died from external causes. A histological analysis of the lung parenchyma was carried out to assess the protease profiles and degranulation activity of MCs. In addition, we have analyzed the general blood test, coagulogram, and C-reactive protein. The content of tryptase-positive MCs (Try-MCs) in the lungs of patients with COVID-19 was higher than in controls, but their degranulation activity was lower. The indicators of chymase-positive MCs (Chy-MCs) were significantly lower than in the controls, while the content of CPA3-positive MCs (CPA3-MCs) and their degranulation activity were higher in patients with COVID-19. In addition, we have demonstrated the existence of correlations (positive/negative) between the content of Try-MCs, Chy-MCs, and CPA3-MCs at different states of their degranulation and presence (co-adjacent/single) and the levels of various immune cells (neutrophils, eosinophils, basophils, and monocytes) and other important markers (blood hemoglobin, activated partial thromboplastin time (aPTT), international normalized ratio (INR), and fibrinogen). Thus, the identified patterns suggest the numerous and diverse mechanisms of the participation of MCs and their proteases in the pathogenesis of COVID-19, and their impact on the inflammatory process and coagulation status. At the same time, the issue requires further study in larger cohorts of patients, which will open up the possibility of using drugs acting on this link of pathogenesis to treat lung damage in patients with COVID-19.

11 December 2022 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
ABAndrey Budnevsky
Andrey Budnevsky
SASergey Avdeev
Sergey Avdeev
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
SFSofia Feigelman
Sofia Feigelman
OCO. N. Choporov
O. N. Choporov
APA. V. Pertsev
A. V. Pertsev
Cough is a frequent manifestation of COVID-19 (COronaVIrus Disease 2019), therefore, it has an important diagnostic value. There is little information about the characteristics of cough of COVID-19 patients in the literature. To perform a spectral analysis of cough sounds in COVID-19 patients in comparison with induced cough of healthy individuals. Methods. The main group consisted of 218 COVID-19 patients (48.56% – men, 51.44% – women, average age 40.2 (32.4; 50.1) years). The comparison group consisted of 60 healthy individuals (50.0% men, 50.0% women, average age 41.7 (31.2; 53.0) years) who were induced to cough. Each subject had a cough sound recorded, followed by digital processing using a fast Fourier transform algorithm. The temporal-frequency parameters of cough sounds were evaluated: duration (ms), the ratio of the energy of low and medium frequencies (60 – 600 Hz) to the energy of high frequencies (600 – 6 000 Hz), the frequency of the maximum sound energy (Hz). These parameters were determined in relation to both the entire cough and individual phases of the cough sound. Results. Significant differences were found between some cough parameters in the main group and in the comparison group. The total duration of the coughing act was significantly shorter in patients with COVID-19, in contrast to the induced cough of healthy individuals (T = 342.5 (277.0; 394.0) – in the main group; T (c) = 400.5 (359.0; 457.0) – in the comparison group; p = 0.0000). In addition, it was found that the cough sounds of COVID-19 patients are dominated by the energy of higher frequencies as compared to the healthy controls (Q = 0.3095 (0.223; 0.454) – in the main group; Q (c) = 0.4535 (0.3725; 0.619) – in the comparison group; p = 0.0000). The maximum frequency of cough sound energy in the main group was significantly higher than in the comparison group (Fmax = 463.0 (274.0; 761.0) – in the main group; Fmax = 347 (253.0; 488.0) – in the comparison group; p = 0.0013). At the same time, there were no differences between the frequencies of the maximum energy of cough sound of the individual phases of cough act and the duration of the first phase. Conclusion. The cough of patients with COVID-19 is characterized by a shorter duration and a predominance of high-frequency energy compared to the induced cough of healthy individuals.

16 April 2024 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ABAndrey Budnevsky
Andrey Budnevsky
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
SASergey Avdeev
Sergey Avdeev
OCO N Choporov
O N Choporov
SFSofia Feigelman
Sofia Feigelman
AMA V Maksimov
A V Maksimov
Aim. To evaluate the possibility of using spectral analysis of cough sounds in the diagnosis of a new coronavirus infection COVID-19. Materials and methods. Spectral toussophonobarography was performed in 218 patients with COVID-19 [48.56% men, 51.44% women, average age 40.2 (32.4; 51.0)], in 60 healthy individuals [50% men, 50% women, average age 41.7 (32.2; 53.0)] with induced cough (by inhalation of citric acid solution at a concentration of 20 g/l through a nebulizer). The recording was made using a contact microphone located on a special tripod at a distance of 15–20 cm from the face of the subject. The resulting recordings were processed in a computer program, after which spectral analysis of cough sounds was performed using Fourier transform algorithms. The following parameters of cough sounds were evaluated: the duration of the cough act (ms), the ratio of the energy of low frequencies (60–600 Hz) to the energy of high frequencies (600–6000 Hz), the frequency of the maximum energy of the cough sound (Hz). Results. After statistical processing, it was found out that the parameters of the cough sound of COVID-19 patients differ from the cough of healthy individuals. The obtained data were substituted into the developed regression equation. Rounded to integers, the resulting number had the following interpretation: "0" – there is no COVID-19, "1" – there is COVID-19. Conclusion. The technique showed high levels of sensitivity and specificity. In addition, the method is characterized by sufficient ease of use and does not require expensive equipment, therefore it can be used in practice for timely diagnosis of COVID-19.

21 January 2025 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
ABAndrey Budnevsky
Andrey Budnevsky
SASergey Avdeev
Sergey Avdeev
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
SFSofia Feigelman
Sofia Feigelman
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases in the world. Correct treatment of this disease shall account for many additional factors, which can be difficult for primary care physicians. In 2023, the International Primary Care Respiratory Group (IPCRG) developed a new tool for primary care physicians – the COPD “Wheel” that allows for determining the treatment tactics quickly and consulting COPD patients about the main causes and consequences of the disease. The aim of the work was to evaluate whether the innovative tool ensures the integration of physician and patient efforts in achieving COPD control. Conclusion. The COPD Wheel tool ensures timely prescription of drugs suitable for a specific clinical case, as well as significantly improves the patient’s adherence to therapy. As a result, patients with COPD should be expected to have improved quality of life and prognosis.

15 June 2024 in Indian Journal of Medical Specialities
Verified
Journal Article
Open access
ABAndrey V. Budnevsky
Andrey V. Budnevsky
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
SFSofia Feigelman
Sofia Feigelman
AKAvag G. Kitoyan
Avag G. Kitoyan
SBSofia A. Budnevskaya
Sofia A. Budnevskaya
Background: Postinfectious dry cough can significantly worsen the quality of life of patients, which forces them to seek medical help. To relieve this symptom, peripheral antitussive agents are most often used, since they have a high profile of effectiveness and safety. Subjects and Methods: The study used levodropropizine, which was prescribed to a study group consisting of 100 patients with dry postinfectious cough, at a dosage of 10 ml (60 mg) 3 times a day for 7 days. The comparison group consisted of 34 patients with dry postinfectious cough who refused to take levodropropizine or had contraindications to taking it. On the 1st, 4th, and 8th days of the study, complaints were collected, an objective examination, and an assessment of cough intensity using 6-point scales for evaluating day and night cough, as well as a Visual Analog Scale were conducted. In addition, undesirable side effects were assessed at each visit. Results: It was found that during 7 days of treatment with levodropropizine, the intensity of cough on the above-mentioned scales significantly decreased, and no side effects were observed in any patient. Conclusions: The resolution of the cough syndrome occurred faster when taking a peripheral antitussive drug (levodropropizine). Moreover, no side effects were reported in any of the subjects. Therefore, peripheral antitussives have a high efficacy and safety profile against dry postinfectious cough.

12 December 2024 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
ABAndrey Budnevsky
Andrey Budnevsky
SASergey Avdeev
Sergey Avdeev
EOEvgeniy S. Ovsyannikov
Evgeniy S. Ovsyannikov
SFSofia Feigelman
Sofia Feigelman
Dry cough is one of the most common complaints of patients with COVID-19, so it must be treated with antitussives. The effectiveness of prescribed therapy can be controlled by using questionnaires and spectral analysis of cough sounds. The aim was to assess the use of spectral tussophonobarography for monitoring the effectiveness of cough treatment in patients with COVID-19. Methods. The main group consisted of 60 patients with COVID-19 (45% men, 55% women, average age 38.6 (30.1; 49.6) years) with mild or moderate severity and strong complaints of cough. The disease was treated in accordance with clinical recommendations, and antitussives were also used. Cough on the 1st and 8th days of therapy was studied using a visual analogue scale and spectral tussophonobarography, then compared with the induced cough of 30 healthy individuals making up the comparison group (43.3% men and 56.7% women; average age of 36.3 (28.4; 44.8) years). Cough recordings were subjected to a fast Fourier transform algorithm. The following cough characteristics were assessed: duration (ms), ratio of low and medium frequency energy (60 – 600 Hz) to high frequency energy (600 – 6000 Hz), and frequency of maximum sound energy (Hz). Not only of the coughing act as a whole was assessed, but also of each phase separately. Results. On the 8th day of treatment, significant changes in cough characteristics were seen compared to the 1st day, especially in the 2nd phase of the cough act. The duration of cough increased (T = 355.0 (276.0; 407.5) – on the 1st day; T(c) = 432.0 (386.0; 556.0) – on the 8th day; p = 0.0000), lower frequencies began to predominate (Q = 0.281 (0.2245; 0.408) – on the 1st day; Q(c) = 0.4535 (0.3725; 0.619) – on the 8th day; p = 0.0000), the frequency of maximum sound energy decreased (Fmax = 488.5 (282.0; 1220.5) – on the 1st day; Fmax = 347.0 (253.0; 488.0) – on the 8th day; p = 0.0064). No statistically significant differences were found in the studied parameters on the 8th day of treatment as compared with those in healthy individuals. Conclusion. Spectral tussophonobarography revealed that characteristics of cough sounds during treatment of COVID-19 were close to those of healthy individuals.